Business · 23/06/2016Updated: 10/17/2026 · 1 min read
FDA Amends Notice for Pediatric Oncology Subcommittee Meeting
Summary
The US Food and Drug Administration (FDA) has updated the notice for the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee, which was first announced in June 2016, to reflect a change in the meeting procedure.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →